Gu Mi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 3

Top Topics

Health Insurance

Top Venues

Statistics in medicine

Pharmaceutical statistics

Eli Lilly and Company

Oregon State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Eli Lilly and Company

United States

Research Scientist, Statistics - Oncology :: Global Statistical Sciences

Education History

Oregon State University

United States

PHD :: Statistics

Publications

Yuhan Li, Yiding Zhang, Gu Mi, Ji Lin
A seamless phase II/III design with dose optimization for oncology drug development. Statistics in medicine 43 (18) (2024)
Yuhan Li, Yiding Zhang, Gu Mi, Ji Lin
A seamless phase II/III design with dose optimization for oncology drug development. Statistics in medicine (2024)
Gu Mi
Enhancement of the adaptive signature design for learning and confirming in a single pivotal trial. Pharmaceutical statistics 16 (5) (2017)